Mourrain, Philippe
- Stanford University · Psychiatry (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,685
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Psychiatry
NIH Funding · FY2023
Linked Award Amount
$1.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,685
By linked amount among FY2023 PIs
Earliest Year Loaded
2010
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Mourrain, Philippe as a PI. Multi-PI records show the full award amount for context.
- 5R01HL151576-04R01Contact PIFluorescent polysomnography and MCH neurogeneticsStanford University · Psychiatry (NIH department code)$731.4Kaward amount
- 5R01GM136741-03R01Contact PIIn vivo characterization of CNE/SNPs and identification of cis (dys)regulated genesStanford University · Psychiatry (NIH department code)$636.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Mourrain, Philippe as a PI.
FY2023 award administered by Stanford University (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2010First NIH AwardStanford University
- 2011$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #7258
- 2012$2M Cumulative Funding
- 2014R01 Grant Holder
- 2020$5M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #2130
- 2023$10M Cumulative Funding